OppenheimerFunds Inc. lowered its position in shares of Albemarle Co. (NYSE:ALB) by 5.6% in the first quarter, HoldingsChannel reports. The firm owned 269,581 shares of the specialty chemicals company’s stock after selling 16,079 shares during the period. OppenheimerFunds Inc.’s holdings in Albemarle were worth $22,100,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in ALB. Creative Planning increased its holdings in Albemarle by 5.7% in the fourth quarter. Creative Planning now owns 4,451 shares of the specialty chemicals company’s stock valued at $343,000 after buying an additional 242 shares during the last quarter. Stevens Capital Management LP purchased a new position in shares of Albemarle during the fourth quarter worth about $2,055,000. Capital Advisors Inc. OK purchased a new position in shares of Albemarle during the fourth quarter worth about $5,169,000. Nissay Asset Management Corp Japan ADV grew its holdings in shares of Albemarle by 2.8% during the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 8,408 shares of the specialty chemicals company’s stock worth $648,000 after purchasing an additional 229 shares during the last quarter. Finally, MERIAN GLOBAL INVESTORS UK Ltd purchased a new position in shares of Albemarle during the fourth quarter worth about $732,000. Institutional investors and hedge funds own 89.84% of the company’s stock.
In other Albemarle news, SVP Deeanne J. Marlow bought 1,000 shares of the firm’s stock in a transaction dated Monday, May 13th. The stock was acquired at an average price of $70.85 per share, for a total transaction of $70,850.00. Following the completion of the purchase, the senior vice president now owns 1,000 shares of the company’s stock, valued at $70,850. The acquisition was disclosed in a filing with the SEC, which is available through this link. 1.02% of the stock is currently owned by corporate insiders.
Shares of ALB opened at $72.76 on Friday. Albemarle Co. has a fifty-two week low of $63.10 and a fifty-two week high of $108.74. The stock has a market cap of $7.65 billion, a PE ratio of 13.28, a price-to-earnings-growth ratio of 0.75 and a beta of 1.62. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.55 and a quick ratio of 0.96.
Albemarle (NYSE:ALB) last announced its earnings results on Wednesday, May 8th. The specialty chemicals company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.02. Albemarle had a net margin of 20.54% and a return on equity of 15.53%. The business had revenue of $832.06 million during the quarter, compared to the consensus estimate of $827.94 million. During the same quarter in the prior year, the firm earned $1.30 earnings per share. The business’s quarterly revenue was up 1.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Albemarle Co. will post 6.24 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Friday, June 14th will be paid a dividend of $0.3675 per share. The ex-dividend date of this dividend is Thursday, June 13th. This represents a $1.47 annualized dividend and a dividend yield of 2.02%. Albemarle’s dividend payout ratio (DPR) is 26.82%.
TRADEMARK VIOLATION WARNING: This report was originally reported by Markets Daily and is owned by of Markets Daily. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.themarketsdaily.com/2019/06/14/albemarle-co-nysealb-position-lessened-by-oppenheimerfunds-inc.html.
Albemarle Company Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets.
Featured Story: What are the FAANG Stocks?
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.